Tradestie Institutional Equity Comparison Engine

ISRG vs RBOT.WS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ISRG Overall Edge

ISRG Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Intuitive Surgical Inc. (ISRG) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ISRG trades at 32.0x Forward P/E with 31.7% operating margin (+21.7% YoY revenue) versus RBOT.WS at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ISRG sits in SURGE (69th %ile IV; Dealer Gamma Walls on Pro) against RBOT.WS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ISRG
ISRG 32.0x vs RBOT.WS N/M Fwd P/E
Growth & Margin Winner ISRG
Op Margin 31.7% vs N/A ยท YoY +21.7% vs N/A
Momentum & Technical Winner ISRG
1Y -29.3% vs -67.2% ยท 52W Pos 26% vs 0%
Options & Structure Winner ISRG
SURGE (69th %ile IV) vs UNCLASSIFIED (N/A IV)
ISRG NASDAQ
Intuitive Surgical Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$399.05
-2.01% 1D
Market Cap $141.2B
1M Return -10.09%
1Y Return -29.33%
Forward P/E 32.0x
Unified AI Score
43.8 / 100 HOLD
Tech 32.0 Fund 47.0 Flow 58.0 Mom 56.0
RBOT.WS NYSE
Vicarious Surgical Inc. Warrants, each whole warrant exercisable for 1/30th of a share of Class A Common Stock at an exercise price of $345.00
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.01
-24.77% 1D
Market Cap N/A
1M Return -67.2%
1Y Return -67.2%
Forward P/E N/M
Unified AI Score
50.1 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ISRG -29.33% RBOT.WS -67.2% Spread: +68.5 pp (ISRG Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ISRG TTM Op. Margin: 31.7% RBOT.WS TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ISRG vs RBOT.WS. Trailing 12-month operating profitability (ISRG 31.7% vs RBOT.WS N/A) and valuation multiples (ISRG 32.0x vs RBOT.WS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ISRG (9) vs RBOT.WS (1)
Institutional Metric ISRG RBOT.WS Criterion Row Winner
Market Capitalization Scale $141.2B N/A Larger Scale ISRG
Trailing P/E Ratio Valuation 49.2x N/M Lower Multiple ISRG
Forward P/E Ratio Valuation 32.0x N/M Lower Multiple ISRG
Revenue Growth (YoY) Growth +21.7% N/A Higher Growth ISRG
Operating Margin (TTM) Profitability 31.7% N/A Higher Margin ISRG
Net Profit Margin Profitability 25.5% N/A Higher Margin ISRG
Return on Equity (ROE) Capital Efficiency 17.9% N/A Higher ROE ISRG
52-Week Range Position Momentum 26% ($329โ€“$604) 0% ($0โ€“$0) Stronger Trend ISRG
Beta / 30D Volatility Risk Regime 0.81ฮฒ ยท 44% Vol N/A Lower Realized Risk ISRG
Unified Institutional Score Composite Signal 43.8 / 100 (HOLD) 50.1 / 100 (HOLD) Higher Composite RBOT.WS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ISRG vs RBOT.WS Buy Guide
ISRG SURGE
12d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 69th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live ISRG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
RBOT.WS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live RBOT.WS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ISRG nor RBOT.WS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.